PHARMACOKINETICS OF FLUOROURACIL BOLUS (5-FU)

Clinical trials for PHARMACOKINETICS OF FLUOROURACIL BOLUS (5-FU) explained in plain language.

Never miss a new study

Get alerted when new PHARMACOKINETICS OF FLUOROURACIL BOLUS (5-FU) trials appear

Sign up with your email to follow new studies for PHARMACOKINETICS OF FLUOROURACIL BOLUS (5-FU), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug aims to turn immune system against stomach cancer

Disease control Ongoing

This study is testing an experimental drug called zolbetuximab for people with advanced stomach or gastroesophageal junction cancer. The drug targets a specific protein (CLDN18.2) found on many of these tumors, aiming to flag them for the body's own immune system to attack. Resea…

Matched conditions: PHARMACOKINETICS OF FLUOROURACIL BOLUS (5-FU)

Phase: PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

PHARMACOKINETICS OF FLUOROURACIL BOLUS (5-FU)

Get alerted when new PHARMACOKINETICS OF FLUOROURACIL BOLUS (5-FU) trials appear

New drug aims to turn immune system against stomach cancer